Vir Biotechnology Inc
NASDAQ:VIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Almonty Industries Inc
NASDAQ:ALM
|
CA |
|
Epiroc AB
F:3AD2
|
SE |
|
Charoen Pokphand Foods PCL
OTC:CHPFF
|
TH |
|
C
|
Cogobuy Group
F:7C3
|
CN |
|
TrustCo Bank Corp N Y
NASDAQ:TRST
|
US |
|
N
|
Naspers Ltd
DUS:NNW
|
ZA |
|
E
|
Evonik Industries AG
XHAM:EVK
|
DE |
|
S
|
SPX Technologies Inc
F:SPW0
|
US |
|
R
|
Restaurant Brands International LP
OTC:RSTRF
|
CA |
|
Kone Corp
F:KC40
|
FI |
|
E
|
Epiroc AB
OTC:EPIPF
|
SE |
|
T
|
Tata Motors Ltd
NSE:TMCV
|
IN |
|
A
|
Abcourt Mines Inc
SWB:AML
|
CA |
|
Cullman Bancorp, Inc.
OTC:CULL
|
US |
Bankruptcy Probability
Vir Biotechnology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vir Biotechnology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
1.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vir Biotechnology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vir Biotechnology Inc has no debt.
You can find a full breakdown on its Balance Sheet.